menu
    • menu
    [{"orgOrder":0,"company":"Nimble Science","sponsor":"University of Calgary | Lallemand Health Solutions","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"CANADA","productType":"Probiotic","year":"2020","type":"Inapplicable","leadProduct":"Probiotic","moa":"Immune","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Nimble Science","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nimble Science \/ University of Calgary | Lallemand Health Solutions","highestDevelopmentStatusID":"1","companyTruncated":"Nimble Science \/ University of Calgary | Lallemand Health Solutions"},{"orgOrder":0,"company":"Nimble Science","sponsor":"LALLEMAND HEALTH SOLUTIONS","pharmaFlowCategory":"DU","therapeuticArea":"Gastroenterology","country":"CANADA","productType":"Probiotic","year":"2024","type":"Inapplicable","leadProduct":"Probiotic","moa":"Immune","graph1":"Gastroenterology","graph2":"Undisclosed","graph3":"Nimble Science","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Gastroenterology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nimble Science \/ Lallemand Health Solutions","highestDevelopmentStatusID":"1","companyTruncated":"Nimble Science \/ Lallemand Health Solutions"},{"orgOrder":0,"company":"Nimble Science","sponsor":"IGY Immune Technologies & Life Sciences Inc.","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"CANADA","productType":"Dietary Supplement","year":"2024","type":"Inapplicable","leadProduct":"Igy Supplement","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Phase I","graph3":"Nimble Science","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nimble Science \/ IGY Immune Technologies & Life Sciences Inc.","highestDevelopmentStatusID":"6","companyTruncated":"Nimble Science \/ IGY Immune Technologies & Life Sciences Inc."},{"orgOrder":0,"company":"Nimble Science","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"CANADA","productType":"Dietary Supplement","year":"2024","type":"Inapplicable","leadProduct":"Milk","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Nimble Science","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nimble Science \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Nimble Science \/ Undisclosed"},{"orgOrder":0,"company":"Nimble Science","sponsor":"University of Calgary","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"CANADA","productType":"Dietary Supplement","year":"2024","type":"Inapplicable","leadProduct":"Nutritional Supplement","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Phase I","graph3":"Nimble Science","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nimble Science \/ University of Calgary","highestDevelopmentStatusID":"6","companyTruncated":"Nimble Science \/ University of Calgary"},{"orgOrder":0,"company":"Nimble Science","sponsor":"Valerie Taylor","pharmaFlowCategory":"DU","therapeuticArea":"Psychiatry\/Psychology","country":"CANADA","productType":"Probiotic","year":"2023","type":"Inapplicable","leadProduct":"Fecal Microbiota","moa":"Undisclosed","graph1":"Psychiatry\/Psychology","graph2":"Phase II","graph3":"Nimble Science","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Psychiatry","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Nimble Science \/ Valerie Taylor","highestDevelopmentStatusID":"8","companyTruncated":"Nimble Science \/ Valerie Taylor"}]

    Find Clinical Drug Pipeline Developments & Deals by Nimble Science

    Menu

    Nimble Science

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Nimble Science

                            Canada arrow
                            Bio-Europe Autumn
                            Not Confirmed

                            Nimble Science

                            Canada arrow
                            Bio-Europe Autumn
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Nutritional Supplement

                            Therapeutic Area : Endocrinology

                            Study Phase : Phase I

                            Sponsor : University of Calgary

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Assessing Gut Microbiome Changes Before and After an Oral Nutritional Supplement Intake Using the SIMBA Capsul...

                            Details : Nutritional Supplement is a Dietary Supplement drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Diabetes Mellitus, Type 2.

                            Product Name : Undisclosed

                            Product Type : Dietary Supplement

                            Upfront Cash : Inapplicable

                            November 25, 2024

                            Lead Product(s) : Nutritional Supplement

                            Therapeutic Area : Endocrinology

                            Highest Development Status : Phase I

                            Sponsor : University of Calgary

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Nimble Science

                            Canada arrow
                            Bio-Europe Autumn
                            Not Confirmed

                            Nimble Science

                            Canada arrow
                            Bio-Europe Autumn
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Igy Supplement

                            Therapeutic Area : Undisclosed

                            Study Phase : Phase I

                            Sponsor : IGY Immune Technologies & Life Sciences Inc.

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Assessing the Safety of an IGY Supplement on the Gut Microbiome

                            Details : Igy Supplement is a Dietary Supplement drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.

                            Product Name : Undisclosed

                            Product Type : Dietary Supplement

                            Upfront Cash : Inapplicable

                            November 22, 2024

                            Lead Product(s) : Igy Supplement

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Phase I

                            Sponsor : IGY Immune Technologies & Life Sciences Inc.

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            Nimble Science

                            Canada arrow
                            Bio-Europe Autumn
                            Not Confirmed

                            Nimble Science

                            Canada arrow
                            Bio-Europe Autumn
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Milk

                            Therapeutic Area : Undisclosed

                            Study Phase : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            The Digestion of Protein Powders in Healthy Participants Using SIMBA and LIMBA Capsule

                            Details : Milk is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Food Science.

                            Product Name : Undisclosed

                            Product Type : Dietary Supplement

                            Upfront Cash : Inapplicable

                            May 01, 2024

                            Lead Product(s) : Milk

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            04

                            Nimble Science

                            Canada arrow
                            Bio-Europe Autumn
                            Not Confirmed

                            Nimble Science

                            Canada arrow
                            Bio-Europe Autumn
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Probiotic

                            Therapeutic Area : Gastroenterology

                            Study Phase : Undisclosed

                            Sponsor : LALLEMAND HEALTH SOLUTIONS

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            The Safety And Efficacy Of A Probiotic Intervention On Lactulose Hydrogen Breath Test-Positive Patients And Re...

                            Details : This is a Probiotic drug candidate, which is currently being evaluated in clinical studies for the treatment of Small Intestinal Bacterial Overgrowth.

                            Product Name : Undisclosed

                            Product Type : Probiotic

                            Upfront Cash : Inapplicable

                            March 19, 2024

                            Lead Product(s) : Probiotic

                            Therapeutic Area : Gastroenterology

                            Highest Development Status : Undisclosed

                            Sponsor : LALLEMAND HEALTH SOLUTIONS

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            05

                            Nimble Science

                            Canada arrow
                            Bio-Europe Autumn
                            Not Confirmed

                            Nimble Science

                            Canada arrow
                            Bio-Europe Autumn
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Fecal Microbiota

                            Therapeutic Area : Psychiatry/Psychology

                            Study Phase : Phase II

                            Sponsor : Valerie Taylor

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            A Clinical Trial of Fecal Microbiota Transplantation in a Population With Obsessive-compulsive Disorder

                            Details : Fecal Microbiota is a Probiotic drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Obsessive-Compulsive Disorder.

                            Product Name : Undisclosed

                            Product Type : Probiotic

                            Upfront Cash : Inapplicable

                            February 09, 2023

                            Lead Product(s) : Fecal Microbiota

                            Therapeutic Area : Psychiatry/Psychology

                            Highest Development Status : Phase II

                            Sponsor : Valerie Taylor

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            06

                            Nimble Science

                            Canada arrow
                            Bio-Europe Autumn
                            Not Confirmed

                            Nimble Science

                            Canada arrow
                            Bio-Europe Autumn
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Probiotic

                            Therapeutic Area : Undisclosed

                            Study Phase : Undisclosed

                            Sponsor : University of Calgary | Lallemand Health Solutions

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Dietary Intervention Detection in the Small Intestine

                            Details : This is a Probiotic drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.

                            Product Name : Undisclosed

                            Product Type : Probiotic

                            Upfront Cash : Inapplicable

                            July 28, 2020

                            Lead Product(s) : Probiotic

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Undisclosed

                            Sponsor : University of Calgary | Lallemand Health Solutions

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth